drugset / Trial / NCT01863706

Misoprostol Versus Oxytocin for Prevention of Post Partum Hemorrhage

NCT01863706

Phase 1 Completed 400 enrolled Hormozgan University of Medical Sciences
RandomizedParallel-groupDouble-blindPrevention

Summary

Post partum Hemorrhage (PPH) is one of three main causes of death in pregnant women. Oxytocin is widely used for prevention of PPH. Some studies suggested misoprostol as an alternative treatment when Oxytocin isn't available. The aim of this study is to compare the safety and efficacy of Oxytocin and misoprostol for prevention of PPH.

Timeline

Start
2013-05
Primary completion
2013-12
Completion
2013-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Misoprostol Other / unclassified 400 ug Oral
Comparator Oxytocin Peptide 20 iu

Indications

No indication recorded.